These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 37421443)

  • 1. Human-Induced Pluripotent Stem Cell-Based Differentiation of Cardiomyocyte Subtypes for Drug Discovery and Cell Therapy.
    Pan Z; Liang P
    Handb Exp Pharmacol; 2023; 281():209-233. PubMed ID: 37421443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A review of human pluripotent stem cell-derived cardiomyocytes for high-throughput drug discovery, cardiotoxicity screening, and publication standards.
    Mordwinkin NM; Burridge PW; Wu JC
    J Cardiovasc Transl Res; 2013 Feb; 6(1):22-30. PubMed ID: 23229562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced structural maturation of human induced pluripotent stem cell-derived cardiomyocytes under a controlled microenvironment in a microfluidic system.
    Kolanowski TJ; Busek M; Schubert M; Dmitrieva A; Binnewerg B; Pöche J; Fisher K; Schmieder F; Grünzner S; Hansen S; Richter A; El-Armouche A; Sonntag F; Guan K
    Acta Biomater; 2020 Jan; 102():273-286. PubMed ID: 31778832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deep learning detects cardiotoxicity in a high-content screen with induced pluripotent stem cell-derived cardiomyocytes.
    Grafton F; Ho J; Ranjbarvaziri S; Farshidfar F; Budan A; Steltzer S; Maddah M; Loewke KE; Green K; Patel S; Hoey T; Mandegar MA
    Elife; 2021 Aug; 10():. PubMed ID: 34338636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent progress of iPSC technology in cardiac diseases.
    Funakoshi S; Yoshida Y
    Arch Toxicol; 2021 Dec; 95(12):3633-3650. PubMed ID: 34657219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiotoxicity of Antineoplastic Therapies and Applications of Induced Pluripotent Stem Cell-Derived Cardiomyocytes.
    Huang MF; Pang LK; Chen YH; Zhao R; Lee DF
    Cells; 2021 Oct; 10(11):. PubMed ID: 34831045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of KCNJ2 enhances maturation of human-induced pluripotent stem cell-derived cardiomyocytes.
    Zhou J; Cui B; Wang X; Wang H; Zheng J; Guo F; Sun Y; Fan H; Shen J; Su J; Wang J; Zhao H; Tang Y; Gong T; Sun N; Liang P
    Stem Cell Res Ther; 2023 Apr; 14(1):92. PubMed ID: 37061738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human-induced pluripotent stem cells in cardiovascular research: current approaches in cardiac differentiation, maturation strategies, and scalable production.
    Thomas D; Cunningham NJ; Shenoy S; Wu JC
    Cardiovasc Res; 2022 Jan; 118(1):20-36. PubMed ID: 33757124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-mediated maturation of human pluripotent stem cell-derived cardiomyocytes: Towards a better model for cardiotoxicity?
    White MC; Pang L; Yang X
    Food Chem Toxicol; 2016 Dec; 98(Pt A):17-24. PubMed ID: 27265266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug screening using a library of human induced pluripotent stem cell-derived cardiomyocytes reveals disease-specific patterns of cardiotoxicity.
    Liang P; Lan F; Lee AS; Gong T; Sanchez-Freire V; Wang Y; Diecke S; Sallam K; Knowles JW; Wang PJ; Nguyen PK; Bers DM; Robbins RC; Wu JC
    Circulation; 2013 Apr; 127(16):1677-91. PubMed ID: 23519760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiotoxicity evaluation using human embryonic stem cells and induced pluripotent stem cell-derived cardiomyocytes.
    Zhao Q; Wang X; Wang S; Song Z; Wang J; Ma J
    Stem Cell Res Ther; 2017 Mar; 8(1):54. PubMed ID: 28279214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of human donor cell source on differentiation and function of cardiac induced pluripotent stem cells.
    Sanchez-Freire V; Lee AS; Hu S; Abilez OJ; Liang P; Lan F; Huber BC; Ong SG; Hong WX; Huang M; Wu JC
    J Am Coll Cardiol; 2014 Aug; 64(5):436-48. PubMed ID: 25082575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Trial in a Dish: Personalized Stem Cell-Derived Cardiomyocyte Assay Compared With Clinical Trial Results for Two QT-Prolonging Drugs.
    Blinova K; Schocken D; Patel D; Daluwatte C; Vicente J; Wu JC; Strauss DG
    Clin Transl Sci; 2019 Nov; 12(6):687-697. PubMed ID: 31328865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug Development and the Use of Induced Pluripotent Stem Cell-Derived Cardiomyocytes for Disease Modeling and Drug Toxicity Screening.
    Ovics P; Regev D; Baskin P; Davidor M; Shemer Y; Neeman S; Ben-Haim Y; Binah O
    Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33023024
    [No Abstract]   [Full Text] [Related]  

  • 15. Maturation strategies and limitations of induced pluripotent stem cell-derived cardiomyocytes.
    Wu P; Deng G; Sai X; Guo H; Huang H; Zhu P
    Biosci Rep; 2021 Jun; 41(6):. PubMed ID: 33057659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An impedance-based approach using human iPSC-derived cardiomyocytes significantly improves in vitro prediction of in vivo cardiotox liabilities.
    Koci B; Luerman G; Duenbostell A; Kettenhofen R; Bohlen H; Coyle L; Knight B; Ku W; Volberg W; Woska JR; Brown MP
    Toxicol Appl Pharmacol; 2017 Aug; 329():121-127. PubMed ID: 28546047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Concise Review on Induced Pluripotent Stem Cell-Derived Cardiomyocytes for Personalized Regenerative Medicine.
    Pushp P; Nogueira DES; Rodrigues CAV; Ferreira FC; Cabral JMS; Gupta MK
    Stem Cell Rev Rep; 2021 Jun; 17(3):748-776. PubMed ID: 33098306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human cardiomyocyte generation from pluripotent stem cells: A state-of-art.
    Talkhabi M; Aghdami N; Baharvand H
    Life Sci; 2016 Jan; 145():98-113. PubMed ID: 26682938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arrhythmogenicity Test Based on a Human-Induced Pluripotent Stem Cell (iPSC)-Derived Cardiomyocyte Layer.
    Slotvitsky M; Tsvelaya V; Frolova S; Dementyeva E; Agladze K
    Toxicol Sci; 2019 Mar; 168(1):70-77. PubMed ID: 30388253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single-Cell RNA-Sequencing and Optical Electrophysiology of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes Reveal Discordance Between Cardiac Subtype-Associated Gene Expression Patterns and Electrophysiological Phenotypes.
    Biendarra-Tiegs SM; Li X; Ye D; Brandt EB; Ackerman MJ; Nelson TJ
    Stem Cells Dev; 2019 May; 28(10):659-673. PubMed ID: 30892143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.